· Original article
Aegis General to close Executive Risks insurance division
Aegis General will stop Executive Risks new business and renewals on November 1, 2026, while existing policies and claims handling remain unchanged.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 3,871 · Page 165 / 323
· Original article
Aegis General will stop Executive Risks new business and renewals on November 1, 2026, while existing policies and claims handling remain unchanged.
· Original article
Cemex earnings for Q3 2026 showed revenue rising 8% to $4.59 billion and record operating free cash flow, with profit growth outpacing sales.
· Original article
Revenue guidance updates on October 23 left Booz Allen’s fiscal 2027 midpoint unchanged, while Gentex moved its 2026 forecast to about $2.65 billion.
· Original article
ITC Hotels profit reached ₹202.65 crore in July–September 2026, as revenue rose and the company expanded its hotel portfolio and managed pipeline.
· Original article
WuXi AppTec earnings show nine-month revenue growth of 38.6%, with higher 2026 sales and cash flow targets alongside increased capacity spending.
· Original article
ETF sector buying was positive across all 11 sectors on October 22, 2026, led by energy at $1.45 billion, with Exxon Mobil dominating the purchases.
· Original article
ABREL Q2 results show ₹919 crore profit, largely from discontinued operations, as property collections rise but bookings fall 67% in July–September 2026.
· Original article
Adani Power’s imported coal costs rose about 50% in Q2 FY27, while its Gujarat tariff mechanism delays recovery by more than six months.
· Original article
AmTrust’s completed Wakam acquisition adds French operations and UK capabilities, with the insurer fully capitalised to write and renew business.
· Original article
Xencor shares rose nearly 24% on October 26 after early kidney cancer trial results, with regulatory and Phase 3 plans still ahead.
· Original article
Azimut outlines a 3-by-5-kilometre Wabamisk gold vein field and reports initial Ginger assays ahead of drilling planned for later in 2026.
· Original article
CGDV purchases totaled a reported $519 million on October 22, 2026, led by a new Exxon Mobil holding, with smaller additions to technology stocks.
Charts and market data by TradingView. Availability and delays vary by exchange.